LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 5619 | 10605 | 0.5298 | 0.4829 |
MCF 10A | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 962 | 11071 | 10605 | 1.0440 | 1.0484 |
MCF 10A | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 962 | 387 | 10605 | 0.0365 | -0.0596 |
MCF 10A | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 962 | 253 | 10605 | 0.0239 | -0.0735 |
MCF 10A | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 962 | 11249 | 10605 | 1.0607 | 1.0668 |
MCF 10A | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10541 | 10605 | 0.9940 | 0.9934 |
MCF 10A | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10501 | 10605 | 0.9902 | 0.9892 |
MCF 10A | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10435 | 10605 | 0.9840 | 0.9824 |
MCF 10A | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9634 | 10605 | 0.9085 | 0.8994 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 6164 | 10605 | 0.5812 | 0.5395 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 2316 | 10605 | 0.2185 | 0.1405 |
MCF 10A | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9426 | 10605 | 0.8889 | 0.8778 |
MCF 10A | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 962 | 10762 | 10605 | 1.0148 | 1.0163 |
MCF 10A | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 5630 | 10605 | 0.5309 | 0.4841 |
MCF 10A | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9846 | 10605 | 0.9284 | 0.9213 |
MCF 10A | R406 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9584 | 10605 | 0.9038 | 0.8942 |
MCF 10A | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 962 | 9437 | 10605 | 0.8899 | 0.8789 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 5221 | 10605 | 0.4923 | 0.4417 |
MCF 10A | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 962 | 1004 | 10605 | 0.0947 | 0.0043 |
MCF 10A | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 962 | 786 | 10605 | 0.0741 | -0.0182 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10068 | 10605 | 0.9494 | 0.9444 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9601 | 10605 | 0.9053 | 0.8959 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 962 | 8802 | 10605 | 0.8300 | 0.8131 |
MCF 10A | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 962 | 853 | 10605 | 0.0804 | -0.0113 |
MCF 10A | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 962 | 9800 | 10605 | 0.9241 | 0.9165 |